GATC Biotech adopts Bluebee for genomic analysis

GATC will leverage the Bluebee platform within its own IT infrastructure to support large scale services such as whole genome sequencing. The partnership is part of a systematic effort to offer the fastest processing times for GATC Biotech’s Sequencing Solutions with the highest levels of information privacy and data protection for customers.

By using Bluebee, GATC Biotech benefits from unparalleled scalability, while safeguarding data security and integrity. Importantly, GATC Biotech’s bioinformatics team will keep full control of all pipelines and data management in order to meet the stringent information protection standards of both companies.

All data will be processed and stored in Germany, compliant with EU and German data privacy regulations. “We are delighted to work with Bluebee in our effort to continuously improve our offerings and services,” commented Marco Pietschmann, Director IT & Quality Management of GATC Biotech.

“By keeping full control of data management ourselves, we can truly guarantee the data security of our services as all information will continue to be processed only in Germany. The Bluebee platform will support our guaranteed turn-around times even for the most computationally demanding pipelines, irrespective of the number of samples we need to process in parallel.

The flexibility of the platform permits us to obtain end-to-end integration with our in-house processes. Increased automation was a key requirement for adopting Bluebee’s platform, because as a service provider we want to provide the most streamlined and robust solutions.”

“Bluebee is proud to support GATC Biotech’s sequencing services and to be a partner in their continuous endeavor to innovate and to ensure their customers obtain the highest quality data and service standards,” said Hans Cobben, CEO for Bluebee. “Our industry customers expect and receive a secure and proven service that is highly scalable and reliable.”